| NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells IF Hermans, JD Silk, U Gileadi, M Salio, B Mathew, G Ritter, R Schmidt, ... The Journal of Immunology 171 (10), 5140-5147, 2003 | 565 | 2003 |
| The crystal structure of human CD1d with and without α-galactosylceramide M Koch, VS Stronge, D Shepherd, SD Gadola, B Mathew, G Ritter, ... Nature immunology 6 (8), 819-826, 2005 | 453 | 2005 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 301 | 2021 |
| Nanostructured biocomposite scaffolds based on collagen coelectrospun with nanohydroxyapatite V Thomas, DR Dean, MV Jose, B Mathew, S Chowdhury, YK Vohra Biomacromolecules 8 (2), 631-637, 2007 | 272 | 2007 |
| Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell–mediated immunotherapy JD Silk, IF Hermans, U Gileadi, TW Chong, D Shepherd, M Salio, ... The Journal of clinical investigation 114 (12), 1800-1811, 2004 | 210 | 2004 |
| A Novel Sulindac Derivative That Does Not Inhibit Cyclooxygenases but Potently Inhibits Colon Tumor Cell Growth and Induces Apoptosis with Antitumor ActivityCOX-Independent … GA Piazza, AB Keeton, HN Tinsley, BD Gary, JD Whitt, B Mathew, ... Cancer Prevention Research 2 (6), 572-580, 2009 | 100 | 2009 |
| NSAIDs: old drugs reveal new anticancer targets GA Piazza, AB Keeton, HN Tinsley, JD Whitt, BD Gary, B Mathew, R Singh, ... Pharmaceuticals 3 (5), 1652-1667, 2010 | 69 | 2010 |
| Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors B Mathew, S Srivastava, LJ Ross, WJ Suling, EL White, LK Woolhiser, ... Bioorganic & medicinal chemistry 19 (23), 7120-7128, 2011 | 49 | 2011 |
| Hetero Diels–Alder reactions of o-thioquinones with pentafulvenes: efficient synthesis of novel benzoxathiins V Nair, B Mathew Tetrahedron Letters 41 (35), 6919-6921, 2000 | 35 | 2000 |
| Prognostic model to predict postoperative acute kidney injury in patients undergoing major gastrointestinal surgery based on a national prospective observational cohort study STARSurg Collaborative, ... BJS open 2 (6), 400-410, 2018 | 26* | 2018 |
| A novel quinoline derivative that inhibits mycobacterial FtsZ B Mathew, L Ross, RC Reynolds Tuberculosis 93 (4), 398-400, 2013 | 23 | 2013 |
| Association between peri‐operative angiotensin‐converting enzyme inhibitors and angiotensin‐2 receptor blockers and acute kidney injury in major elective non‐cardiac surgery: a … STARSurg Collaborative, TM Drake, LK Cheung, F Gaba, J Glasbey, ... Anaesthesia 73 (10), 1214-1222, 2018 | 22 | 2018 |
| Hetero Diels-Alder reaction of o-benzoquinones with tetracyclone: An efficient synthesis of benzodioxinone derivatives V Nair, B Mathew, KV Radhakrishnan, NP Rath Tetrahedron 55 (36), 11017-11026, 1999 | 20 | 1999 |
| Diverse amide analogs of sulindac for cancer treatment and prevention B Mathew, JV Hobrath, MC Connelly, RK Guy, RC Reynolds Bioorganic & medicinal chemistry letters 27 (20), 4614-4621, 2017 | 19 | 2017 |
| Screening and Development of New Inhibitors of FtsZ from M. Tuberculosis B Mathew, JV Hobrath, L Ross, MC Connelly, H Lofton, M Rajagopalan, ... PloS one 11 (10), e0164100, 2016 | 19 | 2016 |
| Perioperative intravenous contrast administration and the incidence of acute kidney injury after major gastrointestinal surgery: prospective, multicentre cohort study Journal of British Surgery 107 (8), 1023-1032, 2020 | 17 | 2020 |
| Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library GS Gibbons, A Chakraborty, SM Grigsby, AC Umeano, C Liao, ... European journal of medicinal chemistry 189, 112023, 2020 | 13 | 2020 |
| Potential sialyltransferase inhibitors based on neuraminyl substitution by hetaryl rings B Mathew, RR Schmidt Carbohydrate research 342 (3-4), 558-566, 2007 | 13 | 2007 |
| Hetero Diels–Alder reactions of o-thioquinones with cyclic dienes: an efficient synthesis of novel heterocyclic compounds V Nair, B Mathew, NP Rath, M Vairamani, S Prabhakar Tetrahedron 57 (39), 8349-8356, 2001 | 13 | 2001 |
| A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity. Cancer Prev. Res … GA Piazza, AB Keeton, HN Tinsley, BD Gary, JD Whitt, B Mathew, ... This article presents the new approach to COX-independent NSAID design, 0 | 13 | |
